A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB)
- Citation:
- J Clin Oncol vol 25 (18s) abstr 4508
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 261
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- H. L. Kindler D. Niedzwiecki D. R. Hollis E. A. Oraefo D. Schrag H. I. Hurwitz H. L. Mcleod M. Mulcahy R. L. Schilsky R. M. Goldberg
- Networks:
- Study
- CALGB-80303
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: